{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-017024","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.832496+00:00","generated_at":"2026-06-03T05:44:43.650851+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TenX Keane Acquisition extends business combination deadline to May 18, 2024 with $66,667 deposit","bullets":["Citius Pharma deposited $66,667 into trust to extend deadline from April 18 to May 18, 2024.","Extension funded by unsecured promissory note issued to Citius Pharma; note bears no interest, repayable at close.","Sponsor may extend up to seven additional months through Nov 18, 2024 with similar monthly deposits.","Merger agreement with Citius Oncology dated October 23, 2023 remains pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-017024","json":"https://secwatch.observer/filing/0001493152-24-017024.json","markdown":"https://secwatch.observer/filing/0001493152-24-017024.md","text":"https://secwatch.observer/filing/0001493152-24-017024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224017024/0001493152-24-017024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224017024/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:44:43.650851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ec1425f407d23ae8a01d07214524eec10291747","claim":"CITIUS ONCOLOGY, INC. incurred loan of principal amount of $66,667 with Citius Pharma at no interest maturing repayable in full per the terms of the Merger Agreement.","evidence_excerpt":"On April 26, 2024, Citius Pharma deposited $66,667 into the trust account of the Company (the \"Contribution\") to extend the timeline to complete a business combination for an additional one (1) month period from April 18, 2024 to May 18, 2024 (the \"Extension\"). Such deposit of the Contribution is evidenced by an unsecured promissory note (the \"Note\") issued by the Company in the principal amount of $66,667 to Citius Pharma. The Note bears no interest and is repayable in full per the terms of the Merger Agreement.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1851484/000149315224017024/0001493152-24-017024-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"principal amount of $66,667"},{"label":"Counterparty","value":"Citius Pharma"},{"label":"Rate","value":"no interest"},{"label":"Maturity","value":"repayable in full per the terms of the Merger Agreement"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}